NASDAQ: $QDEL
QuidelOrtho Corporation, a recognized global leader in innovative in vitro diagnostics, has officially announced its participation in a significant industry event: the Raymond James 47th Annual Institutional Investor Conference. This presentation offers a valuable opportunity for investors, analysts, and industry stakeholders to gain direct insight into the company’s strategic direction, recent performance, and future outlook.
Key Presentation Details
Members of the QuidelOrtho management team are scheduled to take the stage to discuss the company’s advancements in diagnostics. The specific timing for their presentation is set for:
- Date: Tuesday, March 3, 2026
- Time: 1:40 p.m. Eastern Time (ET) / 10:40 a.m. Pacific Time (PT)
Accessing the Presentation
For those unable to attend in person or wishing to follow the proceedings remotely, QuidelOrtho is ensuring broad accessibility. Interested parties can access both the live webcast of the presentation and a subsequent replay via the company’s dedicated Investor Relations portal.
To access this information, please visit the “Events & Presentations” section found within the “Investor Relations” page on the QuidelOrtho website: https://ir.quidelortho.com/.
Advancing Diagnostics for a Healthier Future
QuidelOrtho Corporation remains steadfast in its dedication to advancing diagnostics across various critical areas, including clinical chemistry, immunoassay, immunohematology, and molecular testing. As a leading global provider of diagnostic solutions, the company focuses on delivering fast, accurate, and reliable results. These results are essential for improving patient outcomes, whether testing occurs at the point of care, within hospital settings, or in specialized laboratories.
Building upon a strong legacy of innovation, QuidelOrtho collaborates closely with healthcare providers. This partnership approach helps ensure that diagnostic insights are seamlessly connected with practical solutions, thereby defining a clearer, more informed path toward better patient care worldwide.
For further information about the company’s mission and product portfolio, please visit quidelortho.com and follow their updates on major social platforms like LinkedIn, Facebook, and X.